KaNDy Therapeutics

Business Area(s): 


Description: 

KaNDy Therapeutics is a UK based clinical-stage company focused on optimizing the potential of its unique NK-1,3 receptor antagonist NT-814 in the treatment of common, chronic debilitating female sex-hormone related conditions such as post-menopausal vasomotor symptoms (hot-flashes).

Location(s): 
Stevenage
United Kingdom